Ginkgo Bioworks Holdings, Inc.
DNA
$6.79
-$0.45-6.22%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.71M | -82.59M | -80.75M | -80.76M | -60.30M |
| Total Depreciation and Amortization | 16.52M | 8.60M | 8.96M | 168.00K | 19.45M |
| Total Amortization of Deferred Charges | -4.20M | 4.20M | 4.70M | 14.00M | -4.20M |
| Total Other Non-Cash Items | 3.27M | 37.28M | 43.00M | 21.20M | 28.93M |
| Change in Net Operating Assets | -13.15M | -14.18M | -23.59M | 13.78M | -24.13M |
| Cash from Operations | -44.27M | -46.69M | -47.68M | -31.61M | -40.25M |
| Capital Expenditure | -2.62M | -1.93M | -5.00K | 0.00 | -38.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 574.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.71M | 25.07M | 94.53M | -72.82M | -63.85M |
| Cash from Investing | 11.09M | 23.13M | 95.10M | -72.82M | -63.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -19.00K | -25.00K | -24.00K | -98.00K |
| Issuance of Common Stock | 17.05M | -- | 9.15M | 10.32M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -560.00K | -- | -985.00K | -355.00K | -- |
| Cash from Financing | 16.49M | -19.00K | 8.14M | 9.94M | -98.00K |
| Foreign Exchange rate Adjustments | 43.00K | -129.00K | -152.00K | 93.00K | 186.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.65M | -23.70M | 55.41M | -94.39M | -104.05M |